These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36804203)

  • 1. Mutual Cooperativity of Three Allosteric Sites on the Dopamine D1 Receptor.
    Wang X; Hembre EJ; Goldsmith PJ; Beck JP; Svensson KA; Willard FS; Bruns RF
    Mol Pharmacol; 2023 Mar; 103(3):176-187. PubMed ID: 36804203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor.
    Wang X; Heinz BA; Qian YW; Carter JH; Gadski RA; Beavers LS; Little SP; Yang CR; Beck JP; Hao J; Schaus JM; Svensson KA; Bruns RF
    Mol Pharmacol; 2018 Oct; 94(4):1232-1245. PubMed ID: 30111649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Positive Allosteric Modulators of the D
    Luderman KD; Conroy JL; Free RB; Southall N; Ferrer M; Sanchez-Soto M; Moritz AE; Willette BKA; Fyfe TJ; Jain P; Titus S; Hazelwood LA; Aubé J; Lane JR; Frankowski KJ; Sibley DR
    Mol Pharmacol; 2018 Oct; 94(4):1197-1209. PubMed ID: 30068735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders.
    Svensson KA; Hao J; Bruns RF
    Adv Pharmacol; 2019; 86():273-305. PubMed ID: 31378255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D
    Fyfe TJ; Scammells PJ; Lane JR; Capuano B
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis.
    Svensson KA; Heinz BA; Schaus JM; Beck JP; Hao J; Krushinski JH; Reinhard MR; Cohen MP; Hellman SL; Getman BG; Wang X; Menezes MM; Maren DL; Falcone JF; Anderson WH; Wright RA; Morin SM; Knopp KL; Adams BL; Rogovoy B; Okun I; Suter TM; Statnick MA; Gehlert DR; Nelson DL; Lucaites VL; Emkey R; DeLapp NW; Wiernicki TR; Cramer JW; Yang CR; Bruns RF
    J Pharmacol Exp Ther; 2017 Jan; 360(1):117-128. PubMed ID: 27811173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.
    Meltzer HY; Rajagopal L; Matrisciano F; Hao J; Svensson KA; Huang M
    Behav Brain Res; 2019 Apr; 361():139-150. PubMed ID: 30521930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity.
    Lewis MA; Hunihan L; Watson J; Gentles RG; Hu S; Huang Y; Bronson J; Macor JE; Beno BR; Ferrante M; Hendricson A; Knox RJ; Molski TF; Kong Y; Cvijic ME; Rockwell KL; Weed MR; Cacace AM; Westphal RS; Alt A; Brown JM
    J Pharmacol Exp Ther; 2015 Sep; 354(3):340-9. PubMed ID: 26109678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of Muscarinic M
    Okimoto R; Ino K; Ishizu K; Takamatsu H; Sakamoto K; Yuyama H; Fuji H; Someya A; Ohtake A; Ishigami T; Masuda N; Takeda M; Kajioka S; Yoshimura N
    J Pharmacol Exp Ther; 2021 Oct; 379(1):64-73. PubMed ID: 34244231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor.
    Wood M; Ates A; Andre VM; Michel A; Barnaby R; Gillard M
    Mol Pharmacol; 2016 Feb; 89(2):303-12. PubMed ID: 26655303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational insights into diverse binding modes of the allosteric modulator and their regulation on dopamine D1 receptor.
    Chen J; Song Y; Ma L; Jin Y; Yu J; Guo Y; Huang Y; Pu X
    Comput Biol Med; 2024 May; 173():108283. PubMed ID: 38552278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
    Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
    Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders.
    Bruns RF; Mitchell SN; Wafford KA; Harper AJ; Shanks EA; Carter G; O'Neill MJ; Murray TK; Eastwood BJ; Schaus JM; Beck JP; Hao J; Witkin JM; Li X; Chernet E; Katner JS; Wang H; Ryder JW; Masquelin ME; Thompson LK; Love PL; Maren DL; Falcone JF; Menezes MM; Zhang L; Yang CR; Svensson KA
    Neuropharmacology; 2018 Jan; 128():351-365. PubMed ID: 29102759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.
    Arsova A; Møller TC; Hellyer SD; Vedel L; Foster SR; Hansen JL; Bräuner-Osborne H; Gregory KJ
    Mol Pharmacol; 2021 May; 99(5):328-341. PubMed ID: 33602724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
    Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
    J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
    Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
    Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Global and Ligand-Specific Calcium Sensing Receptor Activation Mechanisms.
    Keller AN; Kufareva I; Josephs TM; Diao J; Mai VT; Conigrave AD; Christopoulos A; Gregory KJ; Leach K
    Mol Pharmacol; 2018 Jun; 93(6):619-630. PubMed ID: 29636377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP; Tiberi M
    Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.